Keyphrases
Clinical Trials
100%
Multiple Sclerosis
100%
Disease-modifying Therapy
100%
Trial Design
100%
Multiple Sclerosis Treatment
75%
Endophenotype
50%
Clinical Outcomes
25%
Disease Activity
25%
Targeted Therapy
25%
Molecular Pathogenesis
25%
Response Predictors
25%
Patient Demographics
25%
Heterogeneous Population
25%
Large Sample Size
25%
Response to Treatment
25%
Disease Biomarker
25%
Therapy Response
25%
Predictive Biomarker
25%
Non-responders
25%
Prognosis Prediction
25%
Differential Response
25%
Response Profiles
25%
Epigenetic Biomarkers
25%
Molecular Disorder
25%
Finite number
25%
MRI Outcomes
25%
Validation Phase
25%
Proteomic Biomarkers
25%
Active Comparator
25%
Early Validation
25%
Mathematics
Trial Design
100%
Individual Disease
100%
Heterogeneous Population
100%
Response Profile
100%
Finite Number
100%
Comparator
100%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Endophenotype
100%
Sample Size
50%
Genomics
50%
Proteomics
50%
Magnetic Resonance Imaging
50%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Multiple Sclerosis
100%
Biological Marker
71%
Diseases
71%
Disease Activity
14%
Molecular Pathology
14%
Immunology and Microbiology
Multiple Sclerosis
100%
Endophenotype
28%
Magnetic Resonance Imaging
14%
Sample Size
14%
Proteomics
14%
Neuroscience
Multiple Sclerosis
100%
Endophenotype
28%
Magnetic Resonance Imaging
14%
Proteomics
14%